69321-18-2 Usage
Uses
Used in Histology and Pathology:
Sudan IV is utilized as a staining agent in the fields of histology and pathology. Its lipid-soluble nature allows for the clear visualization and identification of lipids within tissue samples, which is crucial for accurate diagnosis and analysis.
Used in Industrial Applications:
In industrial settings, Sudan IV is employed for its coloring properties. It serves as a color additive in certain products, although its use in the food and cosmetic industries has been restricted in some regions due to potential health concerns.
Used in Laboratory Research:
Sudan IV is also used in laboratory research for staining and identifying lipids in various experimental procedures. Its distinct deep red color facilitates the differentiation of lipids from other cellular components, making it a valuable tool in scientific investigations.
Check Digit Verification of cas no
The CAS Registry Mumber 69321-18-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,3,2 and 1 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 69321-18:
(7*6)+(6*9)+(5*3)+(4*2)+(3*1)+(2*1)+(1*8)=132
132 % 10 = 2
So 69321-18-2 is a valid CAS Registry Number.
69321-18-2Relevant academic research and scientific papers
Low-oxygen dual-targeting AGT inhibitor conjugate, and preparation method and application thereof
-
Paragraph 0074-0079; 0122-0127, (2020/08/09)
The invention relates to the field of medicine preparation, and in particular relates to a low-oxygen dual-targeting AGT inhibitor conjugate, and a preparation method and application thereof. The low-oxygen dual-targeting AGT inhibitor conjugate comprises an AGT inhibitor and a hydrophilic high polymer material, wherein the AGT inhibitor is coupled through low-oxygen responsive groups, and the hydrophilic high polymer material is specifically combined with a CD44 receptor overexpressed on the surfaces of tumor cells. The amphiphilic low-oxygen dual-targeting AGT inhibitor conjugate can form anano-carrier through self-assembly, is used for encapsulating an anti-tumor drug and delivering the anti-tumor drug to a tumor region in a targeting manner, and releases the drug in a low-oxygen environment, so that a targeting anti-tumor effect is achieved, and meanwhile, drug resistance and good water solubility are achieved simultaneously.
